Angiotensin-1 converting enzyme insertion/deletion gene polymorphism in a Mexican population with diabetic nephropathy;Polimorfismo inserción/deleción del gen de la enzima de conversión de la angiotensina en una población mexicana con nefropatía diabética

Medicina Clinica

Volumn 129, Issue 1, 2007, Pages 6-10

  Ortega Pierres, Luz Elena ^a   García, Anel Gómez ^b   Rodríguez Ayala, Ernesto ^b   Figueroa Núñez, Benigno ^b   Farias Rodríguez, Víctor Manuel ^a   Higareda Mendoza, Ana Edith ^a   Pardo Galván, Marco Aurelio ^a   Cortés García, Juan Carlos ^a   López Meza, Joel Edmundo ^a   Álvarez Aguilar, Cleto ^b  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

ACE I D gene polymorphism; Established diabetic nephropathy; Incipient diabetic nephropathy; Risk factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HISPANIC; HUMAN; KIDNEY INJURY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION;

EID: 34548686838     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13106674     Document Type: Article

References (45)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiological approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390-8.
2. Nelson RG, Knowler WC, Bennet PH. Natural history of diabetic nephropathy in non-insulin dependent diabetes mellitus. J Diabetes Complicat. 1991;5:76-8.
3. Larking RG, Dunlop ME. The link between hyperglycaemia and diabetic nephropathy. Diabetologia. 1992;35:499-504.
4. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086-97.
5. Krolewski AS, Quinn M, Angelico MC, Warran JH. Familial factors determine the development of diabetic nephropaty in patients with IDDM. Diabetologia. 1996;39:940-5.
6. Krolewski AS, Canessa H, Warram JH, Laffel LM, Christies AR, Knowler WC, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-5.
7. Carey MR, Siagy MH. The intrarenal renin-angiotensin system and diabetic nephropaty. Trends Endocrinol Metab. 2003;14:274-81.
8. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-69.
9. Lewis EJ. The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am J Hypertens. 2002;15:123S-8S.
10. Rigat BC, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) dipeptidyl-carboxy peptidase. Nucleid Acids Res. 1992;20:1433.
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86: 1343-6.
12. Erman A, Van Kyk DJ, Chen-Gal B, Giler ID, Rosenfeld JB, Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest. 1993;23:615-20.
13. Ruiz JH, Coen BN, Velho G, Cambien F, Cohen D, Passa P, et al. Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91:3662-5.
14. Zee Ryl, Lou Y-K, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin Iconverting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992;184:9-15.
15. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, et al. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphsim, hypertension and metabolic control. Diabetology. 1997;40:327-31.
16. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes. 2002;51:1986-8.
17. Gohda T, Makita Y, Shike T, Kobayashi M, Funabiki K, Haneda M, et al. Association of the DD genotype and development of Japanase type 2 diabetic nephropathy. Clin Nephrol. 2001;56:475-80.
18. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 1995;47:1176-81.
19. Fujisama T, Ikegam H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin 1-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetology. 1998;41:47-53.
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28 Suppl 1:37-42.
21. American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27 Suppl 1:79-83.
22. Cockcroft DW, Gault MH. Prediction of creatine clearance from serum creatinine. Nephron. 1976:16:31-41.
23. Leyva JR, Álvarez AC, López MMG. Función renal en diabéticos tipo 2, determinada por fórmula de Cockcroft-Gault y depuración de creatinina. Rev Med IMSS. 2004;42:5-10.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleid Acids Res. 1988;16:1215.
25. Asamoah A, Yanamandra K, Thurmon FT, Richter R, Green R, Lakin T, et al. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chem Acta. 1996;254:41-6.
26. Fogarty DC, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing [carta]. Lancet. 1994;343:851.
27. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest. 1997;99:1585-95.
28. Kunz R, Bork JP, Fritsche L, Ringer J, Sharma AM. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol. 1998;9:1653-63.
29. Yosida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al. Angiotensin Iconverting enzyme gene polymorphism in noninsulin-dependent diabetes mellitus. Kidney Int. 1996;50:657-64.
30. Toribio R, Pérez-Luque E, Muñoz L. The genetic structure of Mexican mestizos of different locations: blood group systems and microsatellites. Human Inmunol. 2001;62:979-91.
31. Ortiz MA, De Prado A, Donate T, Gallart L, Claramunt H, Hernández M, et al. Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease. Nephrology. 2003;8:171-6.
32. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Sourbier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk. J Hypertens. 1997;15:1579-92.
33. Reneland R, Andren B, Lind L, Andersson PE, Hanni A, Lithell H. Circulating angiotensin converting enzyme levels are increased in concentric, but not eccentric left ventricular hypertrophy in elderly men. J Hypertens. 1997;15: 885-9.
34. Moriyama Y, Ogawa H, Oshima S, Arai H, Takazoe K, Shimomura H, et al. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction. Coron Artery Dis. 1998;9:691-6.
35. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 1996;49:571-7.
36. Rosatto N, Pontremoli R, De Ferrari G, Ravazzolo R. Intron 16 insertion of the angiotensin converting enzyme gene and transcriptional regulation. Nephrol Dial Transplant. 1999;14:868-71.
37. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2006;20:953-70.
38. Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747-803.
39. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensin-converting enzyme gene polymorphism in non-insulin-dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int. 1997;52:473-7.
40. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hyperension and Diabetes. Executive Committees Working Group. Am J Kidney Dis. 2000; 36:646-61.
41. Chen HC, Guh JY, Chang JM, Hsieh MC, Shin SJ, Lai YH. Role of lipid control in diabetic nephropathy. Kidney Int. 2005;67 Suppl 94:60-2.
42. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127-37.
43. Dante A, Álvarez AC, Limones CR, Rodríguez E, Díaz AM, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int. 2005;68 Suppl 97S11-7.
44. Zoccali C. Cardiovascular risk in uremic patients: is it fully explained by classical risk factors? Nephrol Dial Transplant. 2000;15:454-7.
45. Grupo Español de Genética e Hipertensión Arterial de la Sociedad Española de Hipertensión/Liga Española para la Lucha contra la Hipertensión Arterial. Polimorfismos genéticos del sistema renina-angiotensina e hipertensión arterial esencial. Med Clin (Barc). 2002;118:575-9.